Cabaletta Bio (CABA) Invested Capital (2018 - 2025)

Cabaletta Bio's Invested Capital history runs 8 years deep, the most recent figure standing at $112.1 million for Q4 2025.

• In Q4 2025, Invested Capital fell 26.44% year-over-year to $112.1 million; the TTM figure through Dec 2025 stood at $112.1 million (down 26.44% YoY), while the FY2025 annual figure was $112.1 million, down 26.44% from the prior year.
• Invested Capital was $112.1 million for Q4 2025 at Cabaletta Bio, down from $139.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $236.2 million in Q4 2023 to a low of $85.9 million in Q3 2022.
• Historically, Invested Capital has averaged $139.7 million across 5 years, with a median of $119.8 million in 2021.
• The sharpest annual moves came in 2024 and 2025: Invested Capital jumped 141.92% in 2024, then sank 45.18% in 2025.
• A 5-year view of Invested Capital shows it stood at $118.0 million in 2021, then decreased by 11.39% to $104.5 million in 2022, then jumped by 125.98% to $236.2 million in 2023, then plunged by 35.51% to $152.3 million in 2024, then slipped by 26.44% to $112.1 million in 2025.
• The last three Invested Capital figures came in at $112.1 million (Q4 2025), $139.5 million (Q3 2025), and $178.5 million (Q2 2025), per Business Quant data.